Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 2) Regulations 2021
Jurisdiction | Ireland |
Notice of the making of this Statutory Instrument was published in | ||||||||||||||||||
“Iris Oifigiúil” of 15th January, 2021. | ||||||||||||||||||
I, STEPHEN DONNELLY, Minister for Health, in exercise of the powers conferred on me by section 32 (as amended by section 16 of the Irish Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995 (No. 29 of 1995), hereby make the following regulations: | ||||||||||||||||||
1. (1) These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 2) Regulations 2021. | ||||||||||||||||||
(2) The collective citation “the Medicinal Products (Prescription and Control of Supply) Regulations 2003 to 2021” includes these Regulations. | ||||||||||||||||||
2. In these Regulations— | ||||||||||||||||||
“Principal Regulations” means the Medicinal Products (Prescription and Control of Supply) Regulations 2003 ( S.I. No. 540 of 2003 ); | ||||||||||||||||||
“Regulations of 2021” means the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2021 ( S.I. No. 2 of 2021 ). | ||||||||||||||||||
3. The Eighth Schedule (as amended by Regulation 4 of the Regulations of 2021) to the Principal Regulations is amended by inserting the following entry: | ||||||||||||||||||
“ | ||||||||||||||||||
| ||||||||||||||||||
”. | ||||||||||||||||||
4. The Twelfth Schedule (as amended by Regulation 5 of the Regulations of 2021) to the Principal Regulations is amended by inserting the following entry: | ||||||||||||||||||
“ | ||||||||||||||||||
|
To continue reading
Request your trial